婴幼儿肺炎并心力衰竭64例的临床疗效分析

目的分析小儿肺炎并心力衰竭的临床特征，探讨其治疗方法及随访结果。方法搜集2006年8月至2008年10月我院收治的肺炎并心力衰竭的患儿64例，并随机分为A、B、C三组，A、B组各20例，C组24例，三组均进行常规治疗，A组加用纳络酮，B组加用西地兰，C组加用纳络酮和西地兰，观察比较三组的疗效。结果A组：显效11例，有效5例，无效4例；B组：显效13例，有效4例，无效3例；C组：显效17例，有效6例，无效1例。C组疗效与A、B组疗效相比较均有显著性差异（P〈0．01）。结论纳络酮与西地兰联合使用治疗小儿肺炎并心力衰竭有相互协同的作用，促进病情恢复，疗效可靠，值得临床推广应用。

Clinical Efficacy on Infants with Pneumonia and Heart Failure: An Analysis of 64

Objective To analyze the clinical features of children with pneumonia and heart failure, and to explore the treatment and follow-up resnits. Methods 64 cases of children with pneumonia combined with heart failure from August 2006 to October 2008 in our hospital were randomly divided into A, B, C groups. A, B groups were 20 cases each, C group was 24 cases. On the basis of conventional treatment in three groups, A group added with naloxone, B group with cedilanid, C group with naloxone and cedilanid, to observe and compare the efficacy of the three groups. Results A group: 11 cases had obvious effect, 5 cases were effective, 4 cases invalid; B group: 13 cases had obvious effect, effective in 4 cases, 3 cases of invalid; C group: 17 cases had obvious effect, effective in 6 cases, ineffective in 1 case. In contrast to A, B groups, the efficacy of group C was significantly different (P<0.01). Conclusions Naloxone combined with cedilanid treatment for children with pneumonia and heart failure have a mutual synergistic role in promoting the resumption of the disease, which has reliable efficacy and is worthy of clinical application.